Initial results of a cohort of advanced prostate cancer patients in a phase Ia study of NGM120, a first-in-class antiGDNF family receptor alpha like (GFRAL) antibody I. Medic,S. Gulati,H-J. Lenz,D. Mahalingam, J. Thomas, J. Luo,J. Zha, A. DePaoli, C. Tran-Muchowski, C. Tseng, H. LieuANNALS OF ONCOLOGY（2022）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
